Login / Signup

Virtual-screening workflow tutorials and prospective results from the Teach-Discover-Treat competition 2014 against malaria.

Sereina RinikerGregory A LandrumFloriane MontanariSantiago D VillalbaJulie MaierJohanna M JansenW Patrick WaltersAnang A Shelat
Published in: F1000Research (2017)
The first challenge in the 2014 competition launched by the Teach-Discover-Treat (TDT) initiative asked for the development of a tutorial for ligand-based virtual screening, based on data from a primary phenotypic high-throughput screen (HTS) against malaria. The resulting Workflows were applied to select compounds from a commercial database, and a subset of those were purchased and tested experimentally for anti-malaria activity. Here, we present the two most successful Workflows, both using machine-learning approaches, and report the results for the 114 compounds tested in the follow-up screen. Excluding the two known anti-malarials quinidine and amodiaquine and 31 compounds already present in the primary HTS, a high hit rate of 57% was found.
Keyphrases
  • high throughput
  • plasmodium falciparum
  • electronic health record
  • single cell
  • quality improvement
  • machine learning
  • adverse drug